Irvine, California
United States
56
2016-12-08
The entities that hold a legal rights for patent applications filed by inventor Wang Liming:
Liming Wang from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
#2 | 2016-02-18N-(IMIDAZOLIDIN-2-YLIDENE)QUINOLINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
#3 | 2015-08-20NOVEL OXIME DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#4 | 2015-07-30Alpha adrenergic receptor modulators
#5 | 2015-05-28ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
#6 | 2014-11-06Nā(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
#7 | 2014-09-11Steroid conjugates
#8 | 2014-09-11STEROID ANTIBIOTIC CONJUGATES
#9 | 2014-09-11ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
#10 | 2014-09-11ANTIBIOTIC CONJUGATES LINKED WITH STEROID DRUGS
#11 | 2014-09-11Antibiotic Conjugates
#12 | 2014-09-11Cyclosporine A steroid conjugates
#13 | 2014-09-11Antibiotic conjugates directly linked with steroid drugs
#14 | 2014-08-14-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#15 | 2014-07-31NOVEL BENZYL AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#16 | 2014-05-08NOVEL BENZYL AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#17 | 2014-02-27Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
#18 | 2014-02-27NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#19 | 2014-02-27NOVEL OXIME DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#20 | 2013-12-19Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#21 | 2013-12-05N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#22 | 2013-11-21NOVEL OXIME AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#23 | 2013-11-14Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#24 | 2013-11-14Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#25 | 2013-11-07ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
#26 | 2013-11-07Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P) receptors
#27 | 2013-10-31ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE
#28 | 2013-08-22Phenoxy-azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#29 | 2013-08-22Phenoxy derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#30 | 2013-06-13Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#31 | 2013-01-31N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#32 | 2013-01-31N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
#33 | 2012-09-20Alpha adrenergic receptor modulators
#34 | 2012-08-16Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P) receptors
#35 | 2012-08-16Alpha adrenergic receptor modulators
#36 | 2012-06-14Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
#37 | 2012-06-07Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
#38 | 2012-06-07Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor
#39 | 2012-06-07Alkene derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#40 | 2012-06-07Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#41 | 2012-06-07Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#42 | 2012-06-07Benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#43 | 2012-06-07Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#44 | 2012-06-07Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#45 | 2012-06-07Oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#46 | 2012-06-07Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#47 | 2012-05-31Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
#48 | 2012-05-17Ester pro-drugs of [3-(1-(-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
#49 | 2011-05-05Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity
#50 | 2009-11-05Ī±2B and Ī±2C agonists
#51 | 2008-04-014-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity
#52 | 2008-01-03Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#53 | 2005-08-25Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
#54 | 2005-08-11Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#55 | 2005-05-057-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
#56 | 2005-02-15Methods for identifying inhibitors of cytochrome P450RAI
68533 ā